Literature DB >> 11448132

p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription.

K M Regula1, L A Kirshenbaum.   

Abstract

The tumor suppressor p53 is known to regulate gene transcription and apoptosis in mammalian cells. In the present study we ascertain whether these events are mutually dependent and obligatorily linked for induction of apoptosis of ventricular myocytes. Adenovirus mediated gene delivery of wild p53 (p53WT) or a mutant form of p53 (p53MT) defective for gene transcription to ventricular myocytes was confirmed by Western blot analysis. A significant increase in the p53 dependent genes Bax and MDM2 was observed with p53WT but not p53MT. Nuclear DNA visualized by agarose gel electrophoresis revealed nucleosomal DNA laddering in the presence of either p53 protein. Apoptosis was substantiated by Hoechst 33258 nuclear staining. Perturbations to mitochondria consistent with the mitochondrial death pathway, including loss of mitochondrial transmembrane potential Delta(psi)m and cytochrome c release were observed with p53WT and p53MT. An increase in caspase 3-like activity was noted with either p53WT or p53MT protein that was suppressed by the caspase 3 inhibitor Ac-DEVD-CHO. To our knowledge the experiments described here provide the first indication that p53 activates the mitochondrial death pathway and provokes apoptosis of ventricular myocytes independent of DNA binding and de novo gene activation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448132     DOI: 10.1006/jmcc.2001.1405

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  13 in total

1.  Repression of anti-apoptotic genes via AP-1 as a mechanism of apoptosis induction in ventricular cardiomyocytes.

Authors:  A Schlieper; M Anwar; J Heger; H M Piper; G Euler
Journal:  Pflugers Arch       Date:  2006-11-18       Impact factor: 3.657

Review 2.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 3.  Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Authors:  Xuyang Peng; Laura Pentassuglia; Douglas B Sawyer
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

4.  In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation.

Authors:  Susan Erster; Motohiro Mihara; Roger H Kim; Oleksi Petrenko; Ute M Moll
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 5.  Proteasome biology and therapeutics in cardiac diseases.

Authors:  Sanket Kumar Shukla; Khadija Rafiq
Journal:  Transl Res       Date:  2018-09-28       Impact factor: 7.012

6.  Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer.

Authors:  Regine Schneider-Stock; Christian Mawrin; Christiane Motsch; Carsten Boltze; Brigitte Peters; Roland Hartig; Peter Buhtz; Anja Giers; Astrid Rohrbeck; Bernd Freigang; Albert Roessner
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

7.  Cardiomyocyte specific deletion of p53 decreases cell injury during ischemia-reperfusion: Role of Mitochondria.

Authors:  Qun Chen; Jeremy Thompson; Ying Hu; Edward J Lesnefsky
Journal:  Free Radic Biol Med       Date:  2020-07-23       Impact factor: 7.376

8.  Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases.

Authors:  Yu Liu; Mehmet Koyutürk; Jill S Barnholtz-Sloan; Mark R Chance
Journal:  BMC Syst Biol       Date:  2012-06-13

9.  p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults.

Authors:  Charles P Gilman; Sic L Chan; Zhihong Guo; Xiaoxiang Zhu; Nigel Greig; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

10.  Mycalamide A shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors.

Authors:  Sergey A Dyshlovoy; Sergey N Fedorov; Anatoly I Kalinovsky; Larisa K Shubina; Carsten Bokemeyer; Valentin A Stonik; Friedemann Honecker
Journal:  Mar Drugs       Date:  2012-05-30       Impact factor: 6.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.